體位性心動過速合并直立性高血壓一例_Journal of Epilepsy

Authors：

 杜曉萍 ¹ , 郝衛成 ¹ , 李楊波 ¹ ,  劉玉璽 ²

1. ;
2. ;

Corresponding?author：

劉玉璽, Email: liuyuxi2003@163.com

Keywords：

DOI：

10.7507/2096-0247.201600840096

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Citation： 杜曉萍, 郝衛成, 李楊波, 劉玉璽. 體位性心動過速合并直立性高血壓一例. Journal of Epilepsy, 2016, 2(6): 552-554. doi: 10.7507/2096-0247.201600840096 Copy

1.	張清友, 杜軍保.體位性心動過速綜合征發病機制研究進展.中華醫學雜志, 2009, 89(28):2011-2012.
2.	Kanjwal Y,Kosinski D,Grubb BP. The postural orthostatic tachycardia syndrome:definitions,diagnosis,and management. Pacing Clin Electrophysiol, 2003, 26 (8):1747-1757.
3.	田中英高. めまぃ, 立ちㄑらみ. 小兒科診, 2003, 66:1928-1934.
4.	Liao Y, ChenS, Liu X, et al. Flow-mediated vasodilation and endothelium function in children with postural orthostatic tachycardia syndrome. Am J Cardiol, 2010, 106 (3):378-382.
5.	Fessel J, Robertson D. Orthostatic hypertension:when pressor reflexes Overcompensate. Nat Clin Pract Nephrol, 2006, 2(8):424-431.
6.	Kario K, Eguchi K, Hoshide S, et al. U-curve relationship between orthostatic blood pressure change and silent cerebrovascular diseasein elderlyhypertensives:orthostatic hypertension as a new cardiovascularrisk factor. J Am Coll Cardiol, 2002, 40(1):133-141.
7.	Raffai G, Meszaros M, Kollai M, et al. Experimental orthostasis elicits sustained hypertension, which can be prevented by sympathetic blockade in the rat. J Cardiovasc Pharmacol, 2005, 45 (4):354-361.
8.	Kario K. Orthostatic hypertension-a new haemodynamic cardiovascular risk factor. Nat Rev Nephrol, 2013, 9(12):726-738.
9.	Yoshinari M, Wakisaka M, Nakamura U, et al. Orthostatic hypertension in patients with type 2 diabetes. Diabetes Care, 2001, 24(10):1783-1786.
10.	張清友, 杜軍保, 王喻麗. β-受體阻滯劑聯合口服生理鹽水治療兒童體位性心動過速綜合征療效分析. 臨床兒科雜志, 2006, 24(5):357-360.
11.	Grubb BP, Karas B, Kosinski D, et al. Preliminary observationson the use of midodrine hydrochloride in the treatment ofrefractory neurocardiogenic syncope. J Interv Card Electrophysiol, 1999, 3(2):139-143.
12.	Lai CC, Fischer PR, Brands CK, et al. Outcomes in adolescentswith postural orthostatic tachycardia syndrome treatedwith midodrine and beta-blockers. Pacing Clin Electrophysiol, 2009, 32(2):234-238.
13.	Cleophas TJ, Grabowsky I, Niemeyer MG, et al. Paradoxical pressor effects of beta-blockers in standing elderly patients with mild hypertension:a beneficial side effect. Circulation, 2002, 105(14):1669-1671.
14.	Eguchi K, Tomizawa H, Ishikawa J, et al. Effects of new calcium channel blocker, azelnidipine, and amlodipine on baroreflex sensitivity and ambulatory blood pressure. J Cardiovasc Pharmacol, 2007, 49(6):394-400.

1. 張清友, 杜軍保.體位性心動過速綜合征發病機制研究進展.中華醫學雜志, 2009, 89(28):2011-2012.
2. Kanjwal Y,Kosinski D,Grubb BP. The postural orthostatic tachycardia syndrome:definitions,diagnosis,and management. Pacing Clin Electrophysiol, 2003, 26 (8):1747-1757.
3. 田中英高. めまぃ, 立ちㄑらみ. 小兒科診, 2003, 66:1928-1934.
4. Liao Y, ChenS, Liu X, et al. Flow-mediated vasodilation and endothelium function in children with postural orthostatic tachycardia syndrome. Am J Cardiol, 2010, 106 (3):378-382.
5. Fessel J, Robertson D. Orthostatic hypertension:when pressor reflexes Overcompensate. Nat Clin Pract Nephrol, 2006, 2(8):424-431.
6. Kario K, Eguchi K, Hoshide S, et al. U-curve relationship between orthostatic blood pressure change and silent cerebrovascular diseasein elderlyhypertensives:orthostatic hypertension as a new cardiovascularrisk factor. J Am Coll Cardiol, 2002, 40(1):133-141.
7. Raffai G, Meszaros M, Kollai M, et al. Experimental orthostasis elicits sustained hypertension, which can be prevented by sympathetic blockade in the rat. J Cardiovasc Pharmacol, 2005, 45 (4):354-361.
8. Kario K. Orthostatic hypertension-a new haemodynamic cardiovascular risk factor. Nat Rev Nephrol, 2013, 9(12):726-738.
9. Yoshinari M, Wakisaka M, Nakamura U, et al. Orthostatic hypertension in patients with type 2 diabetes. Diabetes Care, 2001, 24(10):1783-1786.
10. 張清友, 杜軍保, 王喻麗. β-受體阻滯劑聯合口服生理鹽水治療兒童體位性心動過速綜合征療效分析. 臨床兒科雜志, 2006, 24(5):357-360.
11. Grubb BP, Karas B, Kosinski D, et al. Preliminary observationson the use of midodrine hydrochloride in the treatment ofrefractory neurocardiogenic syncope. J Interv Card Electrophysiol, 1999, 3(2):139-143.
12. Lai CC, Fischer PR, Brands CK, et al. Outcomes in adolescentswith postural orthostatic tachycardia syndrome treatedwith midodrine and beta-blockers. Pacing Clin Electrophysiol, 2009, 32(2):234-238.
13. Cleophas TJ, Grabowsky I, Niemeyer MG, et al. Paradoxical pressor effects of beta-blockers in standing elderly patients with mild hypertension:a beneficial side effect. Circulation, 2002, 105(14):1669-1671.
14. Eguchi K, Tomizawa H, Ishikawa J, et al. Effects of new calcium channel blocker, azelnidipine, and amlodipine on baroreflex sensitivity and ambulatory blood pressure. J Cardiovasc Pharmacol, 2007, 49(6):394-400.

Previous Article
局灶性皮質發育不良的病理機制

Journal of Epilepsy

體位性心動過速合并直立性高血壓一例

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Format

Content